Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Jan 17 2024

Full Issue

RSV Shots Are Driving Demand For Care Among Older Americans

Axios reports on a "side effect of the new RSV shots," which is that older patients are coming in for checkups. In covid news: hospitalization rates, vaccines and long covid, California's covid guidance, and more.

Axios: "Good News For Health Care": RSV Shots Are Driving Seniors Back To Checkups

One side effect of the new RSV shots for older Americans: More are winding up getting other preventative tests and services during their vaccine appointments. That tidbit came from UnitedHealth Group's year-end earnings report that showed use of medical services were up, prompting health insurer stocks to dip on Friday. (Reed, 1/16)

CBS News: Doctors Say We're Not In The Clear From COVID, Flu, RSV Surge

"While rates of infections have been coming down - visits to emergency departments and so forth - we are seeing increased hospitalization rates for influenza, as well as for COVID," said Dr. Sharon F. Welbel, an infectious disease physician with Cook County Health. Dr. Larry Kociolek, an infectious diseases physician and the medical director for infection prevention and control at Lurie Children's Hospital, said it is not time right now to let down our guard. (Gonzalez, 1/16)

More on the spread of covid —

San Francisco Chronicle: California Updates COVID Guidance For Attending School, Work

California’s health department has changed its COVID-19 guidance, which could have significant implications for people of all ages statewide. The new recommendations, issued last week, reflect a more relaxed approach to isolation and testing, allowing people who test positive for COVID-19 but do not have symptoms to return to work and school. ... “Overall, I think this is reasonable given the high proportion of kids with immunity against COVID,” ... said Peter Chin-Hong, an infectious-disease expert at UCSF. (Vaziri, 1/16)

WMFE: Ladapo's Questions On DNA Integration With COVID Vax Raise Experts' Eyebrows 

Surgeon General Dr. Joseph Ladapo has expressed concerns about the mRNA vaccine. Two Florida experts are confused by his questions, saying they don't make much sense. (Pedersen, 1/16)

CIDRAP: More Evidence Vaccination Reduces Risk Of Long COVID 

A large staggered cohort study from primary care patients in the UK, Spain, and Estonia finds that COVID-19 vaccination consistently reduced the risk of long-COVID symptoms. The study is published in The Lancet Respiratory Medicine. The study used the World Health Organization’s (WHO) definition of post COVID condition, or long COVID, as new or persisting symptoms 3 months after infection that cannot be explained by alternative causes. The WHO recognizes 25 long COVID symptoms, including fatigue, shortness of breath, and cognitive dysfunction. (Soucheray, 1/12)

CIDRAP: Experiment Shows Mule Deer Could Spread SARS-CoV-2

A new study from the US Department of Agriculture shows that elk experimentally infected with SARS-CoV-2 did not shed infectious virus but mounted low-level serologic responses, while mule deer shed and transmitted virus and mounted a more pronounced serologic response to the virus. The authors of the study, published in Emerging Infectious Diseases, said the results suggest mule deer could spread COVID-19. (Soucheray, 1/16)

In related news —

CIDRAP: Report Describes 3 Confirmed Cases Of Deer-To-Human TB Transmission In Michigan

Yesterday in Clinical Infectious Diseases, scientists report on three confirmed people in Michigan who contracted tuberculosis (TB) linked to wild deer and domestic cattle from 2019 to 2022, raising the total number of zoonotic cases in the state to seven since 2002. ... The three infected were a taxidermist, a woman who interacted with deer in the affected area, and a man with no obvious animal exposures and his female household contact. (Van Beusekom, 1/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF